About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Trp73tm1Fmc
targeted mutation 1, Frank McKeon
MGI:1859911
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Trp73tm1Fmc/Trp73tm1Fmc involves: 129S4/SvJae MGI:2174786
hm2
Trp73tm1Fmc/Trp73tm1Fmc involves: 129S4/SvJae * C57BL/6 MGI:5289955
ht3
Trp73tm1Fmc/Trp73+ involves: 129S4/SvJae * C57BL/6 MGI:5289954
cx4
Trp53tm1Tyj/Trp53+
Trp73tm1Fmc/Trp73+
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 MGI:5289964
cx5
Trp63tm1Fmc/Trp63+
Trp73tm1Fmc/Trp73+
involves: 129S4/SvJae * C57BL/6 MGI:5289956


Genotype
MGI:2174786
hm1
Allelic
Composition
Trp73tm1Fmc/Trp73tm1Fmc
Genetic
Background
involves: 129S4/SvJae
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp73tm1Fmc mutation (0 available); any Trp73 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• Background Sensitivity: at weaning, homozygotes of a mixed (unspecified) genetic background exhibit about a 50% reduction in postnatal survival relative to wild-type littermates; postnatal survival is further reduced to less than 25% on a predominantly 129 genetic background

immune system
• pre-weaning homozygotes exhibit severe purulent otitis media, with massive neutrophil infiltrates and mucosecretions detected as early as P2
• in adulthood, >80% of homozygotes display chronic otitis media
• adult homozygotes exhibit chronic infections and inflammation
• in adulthood, >80% of homozygotes display conjunctivitis
• pre-weaning homozygotes exhibit severe purulent rhinitis, with massive neutrophil infiltrates and mucosecretions detected as early as P2
• in adulthood, >80% of homozygotes display chronic, bilateral rhinitis
• at P2, homozygotes exhibit massive sinus inflammation, characterized by mucoserous secretions, neutrophil infiltrates, goblet cell hyperplasia of the surrounding epithelia but absence of obvious Gram-staining pathogens
• in adulthood (but not earlier), homozygotes contain E. coli, P. aerogenes and micrococcal species in affected sites; however, lymphoid and granulocyte populations remain normal

nervous system
• homozygotes exhibit intracranial hemorrhage in ~15% of mortalities
• in homozygotes, the vomeronasal organ, an accessory olfactory struture involved in pheromone detection, lacks pheromone receptors V1R and V2R as well as expression of the olfactory cell adhesion molecule (OCAM), suggesting abnormal pheromone sensory pathways and loss of pheromone responses
• homozygotes show absence of Cajal-Retzius cells in the cortical marginal zone and hippocampal molecular layer; however, no cortical lamination defect is observed
• homozygotes exhibit a mild, congenital hydrocephalus
• some homozygotes display a highly morbid form of communicating hydrocephalus, marked by severely expanded lateral ventricles, a compressed cortex and intraventricular hemorrhage
• homozygotes exhibit hippocampal dysgenesis, as shown by aberrant arrangements of the CA1-CA3 pyramidal cells layer and the dentate gyrus
• in contrast, the neocortex and cerebellum appear unaffected
• mossy fiber and polysialylated neural cell adhesion molecule-positive projections are shorter in the CA3 region
• the mutant dentate gyrus lacks an infrapyramidal blade while the suprapyramidal blade is hypertrophic and extended (J:60896)
• hippocampal neurons in the dentate gyrus show a disorganized distribution and altered morphology (J:180144)
• mossy fiber projections in the CA3 region are reduced in length
• hippocampal neurons in the dentate gyrus show a disorganized distribution and altered morphology
• neurons have a reduced number of branches and shorter dendrites
• cultured DIV 5 cortical neurons show a significant reduction in the number of branches resulting in a decrease in dendritic tree complexity
• the presence of non-obstructive hydrocephalus in some homozygotes indicates possible defects in the production or reabsorption of CSF

hearing/vestibular/ear
• pre-weaning homozygotes exhibit severe purulent otitis media, with massive neutrophil infiltrates and mucosecretions detected as early as P2
• in adulthood, >80% of homozygotes display chronic otitis media

digestive/alimentary system
• most commonly, homozygotes display massive gastrointestinal hemorrhages followed by death
• at P7, homozygotes display an absence of enterocytes
• at P7, homozygotes display a distended and eroded ileum
• at P7, homozygotes exhibit excessive mucosecetion in the duodenum, ileum and cecum

cardiovascular system
• most commonly, homozygotes display massive gastrointestinal hemorrhages followed by death
• homozygotes exhibit intracranial hemorrhage in ~15% of mortalities

growth/size/body
• in homozygotes, the vomeronasal organ, an accessory olfactory struture involved in pheromone detection, lacks pheromone receptors V1R and V2R as well as expression of the olfactory cell adhesion molecule (OCAM), suggesting abnormal pheromone sensory pathways and loss of pheromone responses
• in adulthood, >80% of homozygotes display periorbital edema
• homozygous mutant pups display runting
• at P7, homozygotes display features of wasting, such as excessive digestive mucosecretion

respiratory system
• in homozygotes, the vomeronasal organ, an accessory olfactory struture involved in pheromone detection, lacks pheromone receptors V1R and V2R as well as expression of the olfactory cell adhesion molecule (OCAM), suggesting abnormal pheromone sensory pathways and loss of pheromone responses
• pre-weaning homozygotes exhibit severe purulent rhinitis, with massive neutrophil infiltrates and mucosecretions detected as early as P2
• in adulthood, >80% of homozygotes display chronic, bilateral rhinitis
• at P2, homozygotes exhibit massive sinus inflammation, characterized by mucoserous secretions, neutrophil infiltrates, goblet cell hyperplasia of the surrounding epithelia but absence of obvious Gram-staining pathogens

vision/eye
• in adulthood, >80% of homozygotes display conjunctivitis

craniofacial
• at weaning, homozygotes display domed crania associated with expansion of ventricles, compression of the cortex and intracranial hemorrhaging
• in homozygotes, the vomeronasal organ, an accessory olfactory struture involved in pheromone detection, lacks pheromone receptors V1R and V2R as well as expression of the olfactory cell adhesion molecule (OCAM), suggesting abnormal pheromone sensory pathways and loss of pheromone responses
• in adulthood, >80% of homozygotes display periorbital edema

skeleton
• at weaning, homozygotes display domed crania associated with expansion of ventricles, compression of the cortex and intracranial hemorrhaging

homeostasis/metabolism
• in adulthood, >80% of homozygotes display periorbital edema

behavior/neurological
• male homozygotes lack aggressive responses towards other males
• male homozygotes lack interest in sexually mature females

reproductive system
• matings of female homozygotes with wild-type males fail to result in pregnancies, indicating a defect in conceiving or maintaining embryos

neoplasm
N
• homozygotes aged 2-15 months show no increased susceptibility to spontaneous tumorigenesis

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
otitis media DOID:10754 J:60896




Genotype
MGI:5289955
hm2
Allelic
Composition
Trp73tm1Fmc/Trp73tm1Fmc
Genetic
Background
involves: 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp73tm1Fmc mutation (0 available); any Trp73 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• many mutants die due to chronic infections at 4-5 weeks of age

neoplasm
• 6 of 10 mutants that survive to 10 months of age develop lung adenocarcinomas

respiratory system
• 6 of 10 mutants that survive to 10 months of age develop lung adenocarcinomas




Genotype
MGI:5289954
ht3
Allelic
Composition
Trp73tm1Fmc/Trp73+
Genetic
Background
involves: 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp73tm1Fmc mutation (0 available); any Trp73 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• half of heterozygous mutants are moribound by 14-15 months of age
• by 2 years of age, 36 of 40 mutants had to be sacrificed or died
• mice die from not only the malignant lesions but also from the benign lesions due to such things as obstructed airways from hyperplastic or premalignant lesions in the pharynx, larynx, mouth or tongue

neoplasm
• mutants show an increase in benign premalignant lesions such as squamous cell hyperplasia and multiple lung adenomas
• tumors undergo loss of heterozygosity
• frequency of lung adenomas is 4 times that seen in wild-type mice
• seen in 12.5% of mice

endocrine/exocrine glands

respiratory system
• frequency of lung adenomas is 4 times that seen in wild-type mice

immune system

hematopoietic system




Genotype
MGI:5289964
cx4
Allelic
Composition
Trp53tm1Tyj/Trp53+
Trp73tm1Fmc/Trp73+
Genetic
Background
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53tm1Tyj mutation (12 available); any Trp53 mutation (240 available)
Trp73tm1Fmc mutation (0 available); any Trp73 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• median age of survival is 6 months

neoplasm
• about 45% of mutants develop metastatic tumors
• mutants exhibit an increase in tumor burden compared to heterozygous Trp53 mice, with 75% of mutant mice having multiple tumors of the same or distinct types compared to only 10% in Trp53 heterozygotes
• tumors exhibit loss of heterozygosity of one or both genes
• 22.5% of mutants develop thymic lymphomas
• 15% of mutants develop acinar pancreatic carcinoma
• 15% of mutants develop hepatocellular carcinomas
• 10% of mutants develop lung adenocarcinomas
• 50% of mutants develop sarcomas

endocrine/exocrine glands
• 22.5% of mutants develop thymic lymphomas
• 15% of mutants develop acinar pancreatic carcinoma

respiratory system
• 10% of mutants develop lung adenocarcinomas

liver/biliary system
• 15% of mutants develop hepatocellular carcinomas

hematopoietic system
• 22.5% of mutants develop thymic lymphomas

immune system
• 22.5% of mutants develop thymic lymphomas




Genotype
MGI:5289956
cx5
Allelic
Composition
Trp63tm1Fmc/Trp63+
Trp73tm1Fmc/Trp73+
Genetic
Background
involves: 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp63tm1Fmc mutation (0 available); any Trp63 mutation (60 available)
Trp73tm1Fmc mutation (0 available); any Trp73 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mutants survive for a shorter period of time than either single mutant, with some mutants dying by 6 months of age
• 60% of mutants exhibit increased signs of aging, developing severe degenerative disc disease of the spine between 6 and 18 months of age

neoplasm
• about 30% of mutants develop metastatic tumors
• tumors undergo loss of heterozygosity
• 50% of mutant mice have multiple tumors of the same or distinct types
• mutants that die by 6 months of age develop thymic lymphoma, hemangiosarcoma, or myelogenous leukemia
• mutants that die by 6 months of age develop myelogenous leukemia, thymic lymphoma, or hemangiosarcoma
• mice that die between 6 and 12 months of age most frequently develop carcinomas
• mutants that die by 6 months of age develop hemangiosarcoma, myelogenous leukemia, or thymic lymphoma

skeleton
• 60% of mutants develop severe degenerative disc disease of the spine between 6 and 18 months of age
• degenerative disc disease is consistent with spondylosis and is most frequent in the cervical and thoracic region

behavior/neurological
• in 10% of mutants, degenerative disc disease is so severe, it results in partial paralysis

endocrine/exocrine glands
• mutants that die by 6 months of age develop thymic lymphoma, hemangiosarcoma, or myelogenous leukemia

respiratory system

integument

digestive/alimentary system

hematopoietic system
• mutants that die by 6 months of age develop thymic lymphoma, hemangiosarcoma, or myelogenous leukemia

immune system
• mutants that die by 6 months of age develop thymic lymphoma, hemangiosarcoma, or myelogenous leukemia

craniofacial

growth/size/body





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory